Bicuspid Aortic Valve Clinical Trial
Official title:
The International Multicenter Bicuspid Aortic Valve Stenosis Transcatheter Aortic Valve Replacement Registry
The objective of this study is to evaluate the procedural and clinical outcomes of patients with bicuspid aortic valve stenosis undergoing transcatheter aortic valve replacement.
Status | Recruiting |
Enrollment | 2000 |
Est. completion date | August 15, 2028 |
Est. primary completion date | August 15, 2028 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 19 Years to 129 Years |
Eligibility |
Inclusion Criteria: 1. Age=18 years. 2. Severe aortic stenosis with bicuspid anatomy. 3. NYHA=2 and/or syncope and/or angina. 4. Patient judged by the Heart Team as indicated for TAVR. Exclusion Criteria: 1. Age <18 years 2. Asymptomatic patients 3. Pure aortic regurgitation. |
Country | Name | City | State |
---|---|---|---|
United States | Cedars-Sinai Medical Center | Los Angeles | California |
Lead Sponsor | Collaborator |
---|---|
Cedars-Sinai Medical Center |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Death | Death from any cause | 1 month | |
Primary | Death | Death from any cause | 1 year | |
Primary | Death | Death from any cause | 2 years | |
Primary | Death | Death from any cause | 3 years | |
Primary | Death | Death from any cause | 4 years | |
Primary | Death | Death from any cause | 5 years | |
Secondary | Death from cardiac cause | Death from cardiac cause | 1 month | |
Secondary | Death from cardiac cause | Death from cardiac cause | 1 year | |
Secondary | Death from cardiac cause | Death from cardiac cause | 2 years | |
Secondary | Death from cardiac cause | Death from cardiac cause | 3 years | |
Secondary | Death from cardiac cause | Death from cardiac cause | 4 years | |
Secondary | Death from cardiac cause | Death from cardiac cause | 5 years | |
Secondary | Stroke | disabling and non-disabling stroke | 1 month | |
Secondary | Stroke | disabling and non-disabling stroke | 1 year | |
Secondary | Stroke | disabling and non-disabling stroke | 2 years | |
Secondary | Stroke | disabling and non-disabling stroke | 3 years | |
Secondary | Stroke | disabling and non-disabling stroke | 4 years | |
Secondary | Stroke | disabling and non-disabling stroke | 5 years | |
Secondary | Repeat hospitalization | Number of hospitalizations | 1 month | |
Secondary | Repeat hospitalization | Number of hospitalizations | 1 year | |
Secondary | Repeat hospitalization | Number of hospitalizations | 2 years | |
Secondary | Repeat hospitalization | Number of hospitalizations | 3 years | |
Secondary | Repeat hospitalization | Number of hospitalizations | 4 years | |
Secondary | Repeat hospitalization | Number of hospitalizations | 5 years | |
Secondary | Bleeding | Life-threatening or major bleeding rate | 1 month | |
Secondary | Bleeding | Life-threatening or major bleeding rate | 1 year | |
Secondary | Bleeding | Life-threatening or major bleeding rate | 2 years | |
Secondary | Bleeding | Life-threatening or major bleeding rate | 3 years | |
Secondary | Bleeding | Life-threatening or major bleeding rate | 4 years | |
Secondary | Bleeding | Life-threatening or major bleeding rate | 5 years | |
Secondary | Vascular complication | Major vascular complication | 1 month | |
Secondary | Vascular complication | Major vascular complication | 1 year | |
Secondary | Vascular complication | Major vascular complication | 2 years | |
Secondary | Vascular complication | Major vascular complication | 3 years | |
Secondary | Vascular complication | Major vascular complication | 4 years | |
Secondary | Vascular complication | Major vascular complication | 5 years | |
Secondary | Acute kidney injury (stage 2 or 3) | 1 month | ||
Secondary | Acute kidney injury (stage 2 or 3) | 1 year | ||
Secondary | Acute kidney injury (stage 2 or 3) | 2 years | ||
Secondary | Acute kidney injury (stage 2 or 3) | 3 years | ||
Secondary | Acute kidney injury (stage 2 or 3) | 4 years | ||
Secondary | Acute kidney injury (stage 2 or 3) | 5 years | ||
Secondary | Prosthetic regurgitation by Doppler echocardiography | at discharge | ||
Secondary | Prosthetic regurgitation by Doppler echocardiography | 1 month | ||
Secondary | Prosthetic regurgitation by Doppler echocardiography | 1 year | ||
Secondary | Prosthetic regurgitation by Doppler echocardiography | 2 years | ||
Secondary | Prosthetic regurgitation by Doppler echocardiography | 3 years | ||
Secondary | Prosthetic regurgitation by Doppler echocardiography | 4 years | ||
Secondary | Prosthetic regurgitation by Doppler echocardiography | 5 years | ||
Secondary | Mean aortic valve gradient by Doppler echocardiography | 1 month | ||
Secondary | Mean aortic valve gradient by Doppler echocardiography | 1 year | ||
Secondary | Mean aortic valve gradient by Doppler echocardiography | 2 years | ||
Secondary | Mean aortic valve gradient by Doppler echocardiography | 3 years | ||
Secondary | Mean aortic valve gradient by Doppler echocardiography | 4 years | ||
Secondary | Mean aortic valve gradient by Doppler echocardiography | 5 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT01390181 -
The Effect of Losartan in Bicuspid Aortic Valve Patients
|
N/A | |
Enrolling by invitation |
NCT06212050 -
Feasibility, Safety, and Effectiveness of the ACURATE neo2 Transcatheter Heart Valve for Severe Bicuspid Aortic Stenosis
|
||
Active, not recruiting |
NCT03635424 -
Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study
|
N/A | |
Recruiting |
NCT06153407 -
Genetic Test Based Risk Prediction of Early Calcific Aortic Valve Disease in Patients With Bicuspid Aortic Valve
|
||
Active, not recruiting |
NCT03474159 -
Evaluation of Aortic Stiffness as a Prognostic Indicator of Aortic Dilatation in Patients With Bicuspid Aortic Valve by Multimodal Imaging
|
N/A | |
Not yet recruiting |
NCT06375590 -
NavIIcusp: Bicuspid Aortic Valve Stenosis With Navitor Platform International Experience
|
||
Recruiting |
NCT05739253 -
Changes of Ascending Aortic Diameter in Patients Undergoing Transcatheter Aortic Valve Replacement
|
||
Completed |
NCT01823432 -
Genetic Risks for Bicuspid Aortic Valve Disease
|
||
Completed |
NCT02679261 -
Evaluating the Effectiveness of Atorvastatin on the Progression of Aortic Dilatation and Valvular Degeneration in Patients With Bicuspid Aortic Valve
|
Phase 3 | |
Completed |
NCT01920815 -
Bicuspid Valve Aortopathy Feasibility Study
|
||
Recruiting |
NCT04817735 -
The CASPER Registry
|
N/A | |
Recruiting |
NCT02899624 -
Whole Exome Sequencing in Bicuspid Aortic Valve Patients
|
N/A | |
Recruiting |
NCT05708118 -
Progression of Ascending Aorta Diameters in Bicuspid Aortic Valve After Transcatheter or Surgical Replacement.
|
||
Recruiting |
NCT03495050 -
BIVOLUTX: Bicuspid Aortic Stenosis With Evolut Platform International Experience.
|
||
Completed |
NCT01760668 -
Aortopathy in Persons With Bicuspid Aortic Valve, Turner and Marfan Syndrome
|
N/A | |
Not yet recruiting |
NCT05711693 -
Measurement of Heart-carotid Pulse Wave Velocity (hcPWV) by Laser Doppler Vibrometry (LDV)
|
N/A | |
Completed |
NCT05836363 -
Fate at Long-term of Mild to Moderate Bicuspid Aortic Valve Disease Left Untreated at the Time of Supracoronary Ascending Aorta Replacement
|
||
Completed |
NCT02283970 -
Investigation of Patients With BAV Requiring Valve and/or Aortic Repair (GISSI Outliers VAR)
|
||
Active, not recruiting |
NCT01026571 -
Identification of Genetic Causes of Bicuspid Aortic Valve Disease
|
||
Completed |
NCT00412386 -
Abnormal 3-D MRI Flow Patterns in Adolescents Patients With Bicuspid Aortic Valve
|
N/A |